April 2012 Drug Information Update - Pharmacy Benefits ...
April 2012 Drug Information Update - Pharmacy Benefits ...
April 2012 Drug Information Update - Pharmacy Benefits ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
5 mg single dose vial, package of 1 (NDC 55390-0251-01)<br />
20 mg single dose vial, package of 1 (NDC 55390-0252-01)<br />
40 mg single dose vial, package of 1 (NDC 55390-0253-01)<br />
5 mg Novaplus single dose vial, package of 1 (NDC 55390-0451-01)<br />
20 mg Novaplus single dose vial, package of 1 (NDC 55390-0452-01)<br />
40 mg Novaplus single dose vial, package of 1 (NDC 55390-0453-01)<br />
Mitomycin Powder for Injection (Mannitol Formulation), Accord<br />
5 mg single dose vial (NDC 16729-0115-05)<br />
20 mg single dose vial (NDC 16729-0108-11)<br />
Reason for the Shortage<br />
• Ben Venue voluntarily suspended all manufacturing and distribution in mid-November, 2011.<br />
Product will become available in stages as production resumes.<br />
• Bedford Laboratories has multiple products affected by this suspension of manufacturing.<br />
Availability of all products, including those not manufactured at Ben Venue, is updated as<br />
information changes on the Bedford Laboratories website.<br />
• Accord states the reason for the shortage is increased demand.<br />
Article link: http://www.ashp.org/<strong>Drug</strong>Shortages/Current/Bulletin.aspx?id=433<br />
Source: www.ashp.org<br />
Epinephrine Injection<br />
March 27, <strong>2012</strong><br />
Products Affected - Description<br />
Epinephrine injection, 1 mg/mL, American Regent<br />
1 mL ampule, sulfite-free, package of 25 (NDC 00517-1071-25)<br />
Reason for the Shortage<br />
• American Regent had temporarily suspended manufacture of most drug products in <strong>April</strong>, 2011.<br />
• American Regent resumed manufacturing in Shirley, New York in early-May, 2011.<br />
Article link: http://www.ashp.org/<strong>Drug</strong>Shortages/Current/Bulletin.aspx?id=685<br />
Source: www.ashp.org<br />
Bupivacaine with epinephrine injection<br />
March 27, <strong>2012</strong><br />
Products Affected - Description<br />
Bupivacaine 0.25% with epinephrine<br />
Bupivacaine 0.25% with epinephrine 1:200,000 injection, Hospira<br />
10 mL vial, preservative-free (NDC 00409-9042-01)<br />
50 mL vial, multi-dose (NDC 00409-9043-01)<br />
30 mL vial, preservative-free (NDC 00409-9042-17)<br />
Marcaine 0.25% (with epinephrine 1:200,000) injection, Hospira<br />
10 mL vial, preservative-free (NDC 00409-1746-10)<br />
30 mL vial, preservative-free (NDC 00409-1746-30)<br />
50 mL vial, multi-dose (NDC 00409-1752-50)<br />
Sensorcaine 0.25% (with epinephrine 1:200,000), APP<br />
10 mL vial, preservative-free (NDC 63323-0468-17)<br />
30 mL vial, preservative-free (NDC 63323-0468-37)<br />
50 mL vial, multi-dose (NDC 63323-0461-57)<br />
Bupivacaine 0.5% with epinephrine<br />
Bupivacaine 0.5% with epinephrine 1:200,000 injection, Hospira<br />
63